Mevalonate Kinase Deficiency Overview
Learn About Mevalonate Kinase Deficiency
Mevalonate kinase deficiency is a condition characterized by recurrent episodes of fever, which typically begin during infancy. Each episode of fever lasts about 3 to 6 days, and the frequency of the episodes varies among affected individuals. In childhood the fevers seem to be more frequent, occurring as often as 25 times a year, but as the individual gets older the episodes occur less often.
Mutations in the MVK gene cause mevalonate kinase deficiency. The MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme is involved in the production of cholesterol, which is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.
More than 200 people with mevalonate kinase deficiency have been reported worldwide; the majority of these individuals have HIDS.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Children's Hospital Pediatric Associates, Inc
Fatma Dedeoglu is a Pediatric Rheumatologist and a Pediatrics provider in Boston, Massachusetts. Dr. Dedeoglu and is rated as a Distinguished provider by MediFind in the treatment of Mevalonate Kinase Deficiency. Her top areas of expertise are Localized Scleroderma, Osteomyelitis in Children, Juvenile Idiopathic Arthritis (JIA), Mevalonate Kinase Deficiency, and Thymectomy.
Evans Medical Foundation Inc
Eugene Kissin is a Rheumatologist in Boston, Massachusetts. Dr. Kissin and is rated as a Distinguished provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are Gout, Mevalonate Kinase Deficiency, Bursitis, and Tenosynovitis.
The General Hospital Corporation
Jonathan Hausmann is a Rheumatologist and a Pediatric Rheumatologist in Boston, Massachusetts. Dr. Hausmann and is rated as a Distinguished provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are Mevalonate Kinase Deficiency, PFAPA, Systemic Sclerosis (SSc), and Scleroma.
Summary: This study is designed to explore the genetics and pathophysiology of diseases presenting with intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseases. The following individuals may be eligible for this natural history study: 1) patients with known or suspected familial Mediterranean fever, TRAPS, hyper-IgD syndrome or related disorders; 2) relat...
Summary: Mevalonate kinase deficiency (HyperIgD syndrome, HIDS) is an inborn error of immunity caused by a block in the mevalonate pathway. The subsequent lack of isoprenoids with antiinflammatory properties might contribute to the autoinflammatory nature of the disease. A pilot study aims to verify the safety and efficacy of the dietary supplement Geranylgeraniol, aiming at a mitigation of isoprenoids def...
Published Date: October 01, 2018
Published By: National Institutes of Health